[1]
2025. HIV‑1 drug‑resistance mutations and related risk factors among HIV‑1‑positive individuals receiving first-line antiretroviral therapy. Universa Medicina. 44, 1 (Mar. 2025), 57–64. DOI:https://doi.org/10.18051/UnivMed.2025.v44.57-64.